# Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

> **NCT00213148** · PHASE2 · COMPLETED · sponsor: **EMD Serono** · enrollment: 271 (actual)

## Conditions studied

- Anovulation

## Interventions

- **DRUG:** Anastrozole 1 mg
- **DRUG:** Anastrozole 5 mg
- **DRUG:** Anastrozole 10 mg
- **DRUG:** Clomiphene Citrate 50 mg
- **DRUG:** Clomiphene Citrate 100 mg

## Key facts

- **NCT ID:** NCT00213148
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03-10
- **Primary completion:** 2007-12-12
- **Final completion:** 2007-12-12
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213148, "Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00213148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*